You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

PRELAY Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Prelay patents expire, and what generic alternatives are available?

Prelay is a drug marketed by Sankyo and is included in one NDA.

The generic ingredient in PRELAY is troglitazone. Additional details are available on the troglitazone profile page.

US Patents and Regulatory Information for PRELAY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sankyo PRELAY troglitazone TABLET;ORAL 020719-001 Jan 29, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sankyo PRELAY troglitazone TABLET;ORAL 020719-003 Aug 4, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sankyo PRELAY troglitazone TABLET;ORAL 020719-002 Jan 29, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PRELAY

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sankyo PRELAY troglitazone TABLET;ORAL 020719-001 Jan 29, 1997 ⤷  Try a Trial ⤷  Try a Trial
Sankyo PRELAY troglitazone TABLET;ORAL 020719-002 Jan 29, 1997 ⤷  Try a Trial ⤷  Try a Trial
Sankyo PRELAY troglitazone TABLET;ORAL 020719-001 Jan 29, 1997 ⤷  Try a Trial ⤷  Try a Trial
Sankyo PRELAY troglitazone TABLET;ORAL 020719-002 Jan 29, 1997 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for PRELAY

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0139421 SPC/GB97/084 United Kingdom ⤷  Try a Trial PRODUCT NAME: TROGLITAZONE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK 10949/0277 19970729; UK 10949/0278 19970729; UK 10949/0279 19970729; UK 06384/0005 19970729; UK 06384/0006 19970729; UK 06384/0007 19970729
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.